PMVP
Pmv Pharmaceuticals Inc
NASDAQ: PMVP · HEALTHCARE · BIOTECHNOLOGY
$1.39
-2.11% today
Updated 2026-04-29
Market cap
$74.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.48
Dividend yield
—
52W range
$1 – $2
Volume
0.7M
Pmv Pharmaceuticals Inc (PMVP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+6.1%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+24.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.8%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+9.3%
2026-03-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $-0.34 | +18.1% | $1.50 | $1.64 | +9.3% |
| 2025-11-12 | $-0.40 | +0.0% | $1.33 | $1.36 | +2.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.42 | $-0.34 | +18.1% | — | — |
| 2025-09-30 | $-0.40 | $-0.40 | +0.0% | — | — |
| 2025-06-30 | $-0.39 | $-0.41 | -5.1% | — | — |
| 2025-03-31 | $-0.38 | $-0.34 | +11.3% | — | — |
| 2024-12-31 | $-0.38 | $-0.45 | -18.4% | — | — |
| 2024-09-30 | $-0.35 | $-0.37 | -5.7% | — | — |
| 2024-06-30 | $-0.35 | $-0.02 | +94.3% | — | — |
| 2024-03-31 | $-0.36 | $-0.30 | +16.7% | — | — |
| 2023-12-31 | $-0.39 | $-0.31 | +20.5% | $1.62M | — |
| 2023-09-30 | $-0.45 | $-0.34 | +24.4% | — | — |
| 2023-06-30 | $-0.47 | $-0.38 | +19.1% | — | — |
| 2023-03-31 | $-0.46 | $-0.42 | +8.7% | — | — |
Frequently asked questions
Has Pmv Pharmaceuticals Inc beaten earnings estimates?
Pmv Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +6.1% over the last 4 quarters.
How does PMVP stock react to earnings?
PMVP stock has moved an average of +5.8% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.